Table:
begin	end	state
1	6	cytoplasmic
7	33	transmembrane
34	52	non-cytoplasmic
53	73	transmembrane
74	130	cytoplasmic
131	153	transmembrane
154	168	non-cytoplasmic
169	191	transmembrane
192	212	cytoplasmic
213	234	transmembrane
235	239	non-cytoplasmic
240	257	transmembrane
258	263	cytoplasmic
264	289	transmembrane
290	303	non-cytoplasmic
304	327	transmembrane
328	331	cytoplasmic
332	351	transmembrane
352	356	non-cytoplasmic
357	385	transmembrane
386	396	cytoplasmic
397	416	transmembrane
417	419	non-cytoplasmic

Input:
>SMc00273 FitnessBrowser__Smeli:SMc00273
MTAIMTGLFAALLAISVPVGYALIIAAGAAILWQGGTPTVLAVVKLFQPTQSFPLLAIPF
FILSGSLMMSGTLGQKLVQFAAALVGRFHGGMGQVTVVGSTIFGGVSGSAVAEASALGSM
LIPWQKKEGYPAGFAAAVTASSSTIAGLIPPSIPLILFSTVANSSIASLFSAAVLPGLML
AGGMMIVCYLSGRIRNFPRLTDAGQLKSFGRSMLSALPALAMPFFIILLLRAGIATPTEV
SVIAVFYALLVSLLLYRDLTWERIYAALVGTVITTGVVMLVIAASSLVGHVLITERVPTI
VANWALETLGSAILIILMMNLIMLVVGMFLDLPAAILLLGPTFVAIGHAIGMDPIQLGVM
ICINLSIGLFTPPIGTTLFIGAVIARVPIGAVVKELWPFYIVAAAVLVLMSYVPALTIY

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server